The amount of money people pay out-of-pocket for drugs to treat neurologic conditions like multiple sclerosis, dementia and Parkinson's disease has risen sharply over 12 years, with the most dramatic increase for multiple sclerosis (MS) medications, according to a study published in the May 1, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology. The study, funded by the American Academy of Neurology, found that average out-of-pocket costs for people taking MS drugs were 20 times higher in 2016 than they were in 2004.
* This article was originally published here
